Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan
Author:
Funder
Meiji Seika Pharma Co., Ltd.
Japanese Government
Meiji Seika Pharma Co., Ltd
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology
Reference19 articles.
1. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome;Brunklaus;Brain,2012
2. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO Study Group;Chiron;Lancet,2000
3. Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial;Coppola;Epilepsy Res.,2002
4. DIAVEY Postmarketing Survey in Transparency Commission;DIAVEY,2014
5. Bromides were effective in intractable epilepsy with generalized tonic–clonic seizures and onset in early childhood;Ernst;Bran Dev.,1988
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dravet syndrome: A systematic literature review of the illness burden;Epilepsia Open;2023-10-11
2. Features of epileptic encephalopathy caused by SCN1A mutation;INTERNATIONAL NEUROLOGICAL JOURNAL;2023-09-08
3. Therapeutic efficacy of voltage-gated sodium channel inhibitors in epilepsy;Acta Epileptologica;2023-06-28
4. Optimizing therapy in Dravet syndrome: Why the wait?;Developmental Medicine & Child Neurology;2023-05-17
5. Stiripentol for the treatment of seizures associated with Dravet syndrome in patients 6 months and older and taking clobazam;Expert Review of Neurotherapeutics;2023-03-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3